secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001193125-26-079392
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics provides tax valuation allowance impact: Q4 adjusted EPS $0.47
--------------------------------------------------------------------------

- Released $103.3M U.S. tax valuation allowance in Q4, driving $83.8M net income tax benefit.
- Annual effective tax rate 2025 was (77.0)%; without allowance release it would have been 19.1%.
- Q4 pre-tax income $21.6M; reported net income $105.4M ($2.62 diluted EPS).
- Adjusted net income after 19.1% tax rate: $17.5M ($0.47 diluted EPS).
- Future quarters expected to have tax provision more in line with U.S. statutory rates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526079392/0001193125-26-079392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312526079392/d80286d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-079392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer